Showing results (51-60 of 324) with videos related to
Sort By:
Pageof 33
Cancer Immunology, Immunotherapy : CII|October 12, 2019
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapyDonastas Sakellariou-Thompson, Marie-Andrée Forget, Emily Hinchcliff, et al.Frontiers in Immunology|July 4, 2017
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master RegulatorsYong Qin, Suhendan Ekmekcioglu, Marie-Andrée Forget, et al.Cancer Journal (Sudbury, Mass.)|March 29, 2012
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookRichard Wu, Marie-Andrée Forget, Jessica Chacon, et al.Cancer Research|September 18, 2004
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivoYanyan Lou, Gang Wang, Gregory Lizée, et al.Cancer|October 21, 2010
Prognostic factors for survival in melanoma patients with brain metastasesMichael A Davies, Ping Liu, Susan McIntyre, et al.Melanoma Research|June 13, 2009
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patientsJade Homsi, Agop Y Bedikian, Kevin B Kim, et al.Iscience|October 30, 2024
Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancerYing Ma, Xiangqin Zhao, Jingyan Feng, et al.Cancer Research|December 26, 2003
In vivo antitumor activity of interleukin 21 mediated by natural killer cellsGang Wang, Mary Tschoi, Rosanne Spolski, et al.Journal for Immunotherapy of Cancer|March 2, 2020
T-cell lymphoma secondary to checkpoint inhibitor therapyKartik Anand, Joe Ensor, Sai Ravi Pingali, et al.Journal for Immunotherapy of Cancer|July 6, 2022
Rethinking the immunotherapy numbers gameRebecca A Bekker, Mohammad U Zahid, Jennifer M Binning, et al.Pageof 33